Fundraising Fox

Jeffrey Bird

Investor

Managing Director at Bluebird Ventures

Palo Alto, California

Writes $100K – $5M checks Β· typically $1.5M

About

Founder and Managing Director of Bluebird Ventures who previously spent nearly 20 years as a Managing Director at Sutter Hill Ventures investing in early-stage life sciences. He holds a bachelor's degree, MD, and PhD in Cancer Biology from Stanford, and earlier spent 12 years at Gilead Sciences as an early employee rising to SVP Business Operations.

Experience

  1. Bluebird VenturesManaging Directorcurrent2019 β€” presentPalo Alto, California, United States
  2. Sutter Hill VenturesLimited Partnercurrent2021 β€” present
  3. Sutter Hill VenturesManaging Directorcurrent2002 β€” present
  4. Stanford UniversityMember, Board of Trusteescurrent2026 β€” presentPalo Alto, CA
  5. Stanford Health CareBoard Member and Vice Chaircurrent2022 β€” presentPalo Alto, CA
  6. Nutcracker TherapeuticsInvestorcurrent2020 β€” presentBerkeley, California, United States
  7. EpiriumInvestor and Board Membercurrent2019 β€” presentSan Diego, California, United States
  8. Procyrion, Inc.Investor and Board Membercurrent2019 β€” presentHouston, Texas, United States
  9. GRAIL, Inc.Investorcurrent2016 β€” present
  10. HelixInvestor and Board Membercurrent2015 β€” present
  11. Leyden LabsInvestor2022 β€” 2026Amsterdam, North Holland, Netherlands
  12. Foresight DxInvestor2020 β€” 2026Aurora, CO
  13. Kriya TherapeuticsInvestor2020 β€” 2026Palo Alto, California, United States
  14. Teneobio, Inc.Investor and Board Member2017 β€” 2021
  15. Portola PharmaceuticalsInvestor and Board Member2005 β€” 2020
  16. Forty Seven, Inc.Investor and Lead Director2016 β€” 2020
  17. Verinata Health, Inc.CEO2012 β€” 2013
  18. IlluminaGM2013
  19. Gilead SciencesSenior Vice President of Business Operations1998 β€” 2000
  20. Gilead SciencesVP Corporate Development, Director Scientific Programs and other1988 β€” 1998Foster City, CA

Education

  1. Stanford University School of MedicineMD, Medicine; also Ph.D. Cancer Biology1982 β€” 1988
  2. Stanford UniversityBachelor of Science (BS)1978 β€” 1982

Same school

Shared employers

Deals Β· 11

Kriya TherapeuticsSolo GP

via Bluebird Ventures Β· filed Jun 2021

HelixSolo GP

via Bluebird Ventures

Portola PharmaceuticalsSolo GP

via Bluebird Ventures

ProcyrionSolo GP

via Bluebird Ventures

Verinata HealthSolo GP

via Bluebird Ventures

Attribution from SEC filings, press coverage, and firm rosters. Some rows are inferred. Not right? Tell us.

Network1

Investors connected to Jeffrey in public investor directories β€” a warm-intro map.